Table 3.
Peptide sequencea | # of residues | Pal-peptide mass (Da)b | Ωexperimental (Å2) | Ωpredicted (Å2)c | Difference (%)d |
---|---|---|---|---|---|
LFVALQGCDK | 10 | 1330.79 | 296.2 | 295.1 | 0.4 |
GHLNLMVCIK | 10 | 1364.83 | 304.6 | 298.8 | 1.9 |
LHVLINMCGK | 10 | 1364.83 | 308.4 | 306.3 | 0.7 |
AYPHFCAFAR | 10 | 1657.99 | 352.1 | 353.2 | −0.3 |
LLFGPCILNR | 10 | 1382.86 | 315.7 | 317.9 | −0.7 |
GHLLMVCIK | 9 | 1250.79 | 291.5 | 285.9 | 1.9 |
IGALLVCR | 8 | 1081.73 | 270.8 | 274.1 | −1.2 |
IGAPLVCR | 8 | 1065.69 | 259.5 | 257.5 | 0.8 |
MAWPCISR | 8 | 1438.89 | 324.9 | 328.0 | −1.0 |
MGCFFSK | 7 | 1294.80 | 301.1 | 301.3 | −0.1 |
MGGCTK | 6 | 1071.70 | 265.2 | 262.5 | 1.0 |
Bold letters indicate the number and location of the palmitoylation sites in the peptide sequence.
Palmitoylated peptide masses are calculated from corresponding molecular compositions.
Cross sections here are predicted from ISP values provided in Table 2.
Difference percentage is defined by: